Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Zico’s ‘SPOT!’ Hits the Billboard Charts Again: A Six-Week Streak to Remember!

Daniel Kim Views  

Korean pop artist Zico is enjoying a long run on the U.S. Billboard charts.

KOZ Entertainment

Zico’s digital single “SPOT! (feat. JENNIE)” ranked #43 in Global (Excl. the U.S.) and #81 in Global 200 for six consecutive weeks according to the latest Billboard chart.

“SPOT!” demonstrated its popularity by remaining in the Top 50 in Global (Excl. the U.S.) and Top 100 in the Global 200 for six weeks.

The two Billboard charts rank were based on online streaming and digital downloads from over 200 countries/regions worldwide, unlike the Hot 100 chart, which combines broadcast scores and album sales.

Created to reflect the latest trends in the pop music market, these Billboard charts are considered one of the indicators of global popularity.

Despite the continuous outpour of new music from major artists, “SPOT!” also shined on Korean charts, holding steady at #4 on Melon and #3 on Genie’s latest weekly charts.

Zico is working hard as a host of KBS2‘s The Seasons – Zico’s Artist airing every Friday at 10 PM KST, and has a packed schedule throughout the summer. He will perform at Waterbomb Seoul 2024 at KINTEX on July 5, the 2024 Beer Rock Music Festival in Kaohsiung, Taiwan on July 7, and at KCON LA 2024 for the first time since his solo debut on July 28.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[ENTERTAINMENT] Latest Stories

  • How Real People Shaped Disney’s Most Beloved Animated Characters
  • General Motors Plans to Shift Truck Production to U.S. to Combat Tariff Impact
  • Could Squid Game’s Games Lead to Serious Health Risks? Doctors Reveal the Dangers
  • 'Squid Game' Season 2’s Massive Success—How Much Revenue Will It Make?
  • China’s Illegal 'Squid Game' Season 2 Merch Craze Raises Eyebrows and Anger
  • BTS Members’ Solo Projects Are Crushing It in 2025 – See the Latest Stats

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE&nbsp

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE&nbsp

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE&nbsp

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE&nbsp

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE&nbsp

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE